Samsung nets FDA clearance for new DR algorithm

By staff writers

April 23, 2019 -- Samsung has received U.S. Food and Drug Administration (FDA) 510(k) clearance for version 3.02 of its S-Vue digital radiography (DR) image postprocessing engine, which is designed to significantly lower radiation dose for pediatric patients.

After comparing S-Vue 3.02 with the firm's previous postprocessing engine on phantoms and in clinical studies, Samsung said that DR systems using S-Vue were able to lower dose by up to 45% for pediatric abdomen exams, by 15.5% for pediatric chest studies, and by up to 27% for pediatric skull exams.

S-Vue 3.02 is available on Samsung's GC85A and GM85 DR systems.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking